Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.

Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA; Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators.

Lancet. 2008 May 24;371(9626):1761-8. doi: 10.1016/S0140-6736(08)60763-1.

PMID:
18502300
2.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators.

N Engl J Med. 2003 Nov 13;349(20):1893-906. Epub 2003 Nov 10. Erratum in: N Engl J Med. 2004 Jan 8;350(2):203.

4.

Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man.

Wilson RF, Laughlin DE, Ackell PH, Chilian WM, Holida MD, Hartley CJ, Armstrong ML, Marcus ML, White CW.

Circulation. 1985 Jul;72(1):82-92.

PMID:
3159506
5.

Time course of thallium-201 redistribution after transient myocardial ischemia.

Beller GA, Watson DD, Ackell P, Pohost GM.

Circulation. 1980 Apr;61(4):791-7. No abstract available.

PMID:
7357722
Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk